|
ANP32A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.828600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.951600E-01 |
| Normal-vs-Stage2 |
6.303600E-01 |
| Normal-vs-Stage3 |
5.260300E-02 |
| Normal-vs-Stage4 |
2.545800E-02 |
| Stage1-vs-Stage2 |
5.075600E-01 |
| Stage1-vs-Stage3 |
3.974200E-02 |
| Stage1-vs-Stage4 |
1.730500E-02 |
| Stage2-vs-Stage3 |
8.946300E-02 |
| Stage2-vs-Stage4 |
5.240100E-02 |
| Stage3-vs-Stage4 |
6.513600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.387800E-01 |
| Normal-vs-AfricanAmerican |
4.792200E-01 |
| Normal-vs-Asian |
9.510000E-01 |
| Caucasian-vs-AfricanAmerican |
1.720800E-01 |
| Caucasian-vs-Asian |
4.194200E-01 |
| AfricanAmerican-vs-Asian |
5.650200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.581400E-01 |
| Normal-vs-Female |
2.387000E-01 |
| Male-vs-Female |
1.795840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.774200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.195600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.365800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.129000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.181800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.546600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.362000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.059400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.444200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.796600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.74390000000325E-05 |
| Classical-VS-Follicular |
8.159400E-01 |
| Classical-VS-Other |
7.465000E-01 |
| Classical-VS-Normal |
7.772400E-01 |
| Tall-VS-Follicular |
4.175400E-03 |
| Tall-VS-Other |
1.685620E-01 |
| Tall-VS-Normal |
3.404000E-04 |
| Follicular-VS-Other |
7.652400E-01 |
| Follicular-VS-Normal |
6.963200E-01 |
| Other-VS-Normal |
8.696200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.715400E-01 |
| Normal-vs-N1 |
5.848800E-04 |
| N0-vs-N1 |
2.398800E-04 |
|
|
